Skip to main content
OpenTrials
Completed

NCT Number: NCT01423942

Maturation of the Autonomic Nervous System in Prematures

The purpose of this study is to try to evaluate the maturation of the autonomic nervous system in prematures.

Completed

Looking for future studies?

Notify Me

Key information

Age range

1 day–100 day

Sex eligibility

All sexes

Study type

Observational

Primary location

RMC

Haifa, Israel

About this study

To evaluate the maturation of the autonomic nervous system in prematures by using heart rate variability analyses.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All prematures

Treatment and study plan

Primary outcomes

  1. Herat rate variability (HRV) characteristics

    Time frame: 3 years

    It is well known that maturation of the autonomic nervous system can be detected by heart rate variability in children. The purpose of this study is to apply HRV characteristics in premature infants and try to evaluate if there are noticable changes in these parameters both in "healthy" and diseased premature infants longitudinally during their stay at the NICU. Outcome measures to be studied are very low frequency ( VLF), low-frequency ( LF), high frequency (HF) frequency bands in the power spectrum density (PSD) of HRV records.

Sponsors and collaborators

Lead sponsor

Rambam Health Care Campus

Other

Registry information

Important dates

Study start
2011
Primary completion
2013
Study completion
2014
First posted
Aug 26, 2011
Registry last updated
May 8, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.